Emkay Global
Cholamandalam Investment (Buy)
CMP: ₹142.9
Target: ₹240
Cholamandalam Investment and Finance Company (CIFC) reported weak momentum in disbursement growth for the vehicle finance business, which fell by about 36.3 per cent y-o-y (-20.9 per cent q-o-q) to ₹4,700 crore, whereas Home Equity disbursements fell about 43 per cent y-o-y (-35.1 per cent q-o-q) to ₹590 crore. Though Q4FY20 had merely 10 days of lockdown in March, the slowdown had been severe and is expected to continue in Q1FY21 as well.
In spite of such a sharp decline in disbursement growth, AUM growth remained steady at about 11.6 per cent y-o-y (flat q-o-q) to ₹60,550 crore, backed by lower repayments (due to moratorium). The moratorium is extended for 76 per cent of customers — expected to be leveraged by them for the second stage (June-Aug) also. However, the trend of weak disbursements should gradually be reflected in AUM growth as well.
On a full-year basis, FY20 disbursements registered a decline of about 4 per cent y-o-y, whereas AUM grew by about 16 per cent to ₹66,940 crore in FY20.
The stock trades at about 1.2x FY22E BV and 7.9x FY22E EPS. We currently have a ‘Buy’ rating on the stock, with a target price of ₹240.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.